Potency and timing of antiviral therapy as determinants of duration of SARS-CoV-2 shedding and intensity of inflammatory response

Journal: Science Advances

Published: 2020-11-01

DOI: 10.1126/sciadv.abc7112

Affiliations: 3

Authors: 3

Go to article
Institutions Share
Fred Hutchinson Cancer Research Center (FHCRC), United States of America (USA) 0.78
Clinical Research Division, FHCRC, United States of America (USA) 0.11
UW Medicine, United States of America (USA) 0.11

Return